ReviewFrontiers in immunology2023

HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation.

Qian-Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.